StonvexLoading…
StonvexCore line items from OPEN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.37B | $5.15B | $6.95B | $15.57B |
Operating Income | $-287.00M | $-320.00M | $-386.00M | $-931.00M |
Net Income | $-1.30B | $-392.00M | $-275.00M | $-1.35B |
EPS (Diluted) | $-1.70 | $-0.56 | $-0.42 | $-2.16 |
Total Assets | $2.41B | $3.13B | $3.57B | $6.61B |
Total Liabilities | $1.40B | $2.41B | $2.60B | $5.52B |
Cash & Equivalents | $962.00M | $671.00M | $999.00M | $1.14B |
Free Cash Flow OCF − CapEx | $1.04B | $-620.00M | $2.31B | $693.00M |
Shares Outstanding | 957.25M | 719.99M | 677.64M | 637.39M |